https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-may-2021-w-non-gaap-recs.pdf
Speed to market is essential today, and Avient plays a crucial role in our customers’ success. Assess top 90% of supplier spend for alignment with Avient Sustainability objectives. We are Avient.
https://www.avient.com/investor-center/news/avient-announces-quarterly-dividend
Avient Avient Avient's
https://www.avient.com/investor-center/news/avient-announces-quarterly-dividend-2
Avient Avient Avient's
https://www.avient.com/investor-center/news/avient-announces-quarterly-dividend-1
Avient Avient Avient's
https://www.avient.com/investor-center/news/avient-announces-quarterly-dividend-7
Avient Corporation Avient Avient
https://www.avient.com/investor-center/news/avient-announces-quarterly-dividend-12
Avient Avient Corporation Avient Corporation
https://www.avient.com/resource-center/services/avient-color-prediction-service
Achieving Bright, Beautiful, Sustainable Packaging by l'Oréal and Avient Avient PCR Color Prediction Service - Product Bulletin Avient's Digital Color Prediction Service for Post-Consumer Recycled Content
https://www.avient.com/company/policies-and-governance/avient-corporation-privacy-statement
Communications from Avient. Avient Canada ULC Avient Quality Policy
https://www.avient.com/sites/default/files/2020-10/auto-injector-application-study.pdf
Autoinjector Pen - Avient Application Study.mm (1) AUTO-INJECTOR APPLICATION STUDY M A T E R I A L T E C H N O L O G I E S + S E R V I C E S F O R N E X T G E N E R A T I O N D E S I G N S Avient Corporation 1 Avient Corporation 2 Innovating Design Medical innovations and plastics have gone hand-in-hand to make healthcare safer, cleaner, and more accessible for all. WHY AVIENT? Avient Corporation 12
https://www.avient.com/sites/default/files/2024-01/AVNT January IR Presentation_w Non-Gaap Recs.pdf
Avient’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of Avient and each business segment and to allocate resources. For the same reasons, Avient is unable to address the probable significance of the unavailable information. Avient reflects 2023 adjusted EBITDA guidance of $500M and estimated run-rate CAPEX of $110M. 2023E (%) 27 78 89 83 80 78 74 86 79 76 67 66 55 50 (39) Av ie nt AV PM FM C C Avient Specialty Other Specialty / MULTIPLE EXPANSION Note: Avient reflects 2023 adjusted EBITDA guidance of $500M and closing share price of $41.57.